Benzinga’s Top Pre-Market NASDAQ Losers (MNKD, MAIN, NVAX, QGEN)

MannKind Corporation MNKD dipped 7.04% to $6.34 in the pre-market session. MNKD has announced the proposed offering of about 8,000,000 shares of its common stock. Main Street Capital Corporation MAIN lost 3.71% to $15.04 in the pre-market session. Analysts at Ladenburg Thalmann downgraded MAIN from “buy” to “neutral.” Novavax Inc NVAX fell 0.93% to $2.14 in the pre-market session. NVAX had reported positive results from its pre-clinical toxicology study of its vaccine candidate for preventing respiratory syncytial virus (RSV). Qiagen NV QGEN slipped 0.28% to $18 in pre-market trading. QGEN had reported strong Q2 results. Read more from Benzinga's Company news.